InsidersTradesSigma
Track the 凯莱英 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 凯莱英 has published 6 reports. Market capitalisation: €55.9bn. The latest transaction was filed on 13 September 2024 (Purchase). Among the most active insiders: 徐向科. All data is openly available.
6
Insider Decl.
n/a
Thresholds
€629,112
2 ops.
Buy Volume
€2m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 凯莱英 Buy (bullish), based on 10 analysts. Average price target: CN¥160.45.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,171 of 29,064 companies
50.8
score / 100
Value32
Quality70
FCF yld0.2%
Earn yld2.0%
EV/EBITDA30.4x
ROE6.3%
Gross mgn42%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 September 2024
Declarations6 total
6 of 6 declarations
关于 凯莱英
凯莱英是一家专注于医疗保健和制药领域的公司。它在XSHE市场上市。